Drug Type Small molecule drug |
Synonyms Bimatoprost and Timolol Maleate, Bimatoprost/Timolol, Ganfort + [6] |
Mechanism Prostanoid receptor agonists, β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (19 May 2006), |
Regulation- |
Molecular FormulaC17H28N4O7S |
InChIKeyWLRMANUAADYWEA-NWASOUNVSA-N |
CAS Registry26921-17-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma, Open-Angle | NO | 19 May 2006 | |
Glaucoma, Open-Angle | IS | 19 May 2006 | |
Glaucoma, Open-Angle | EU | 19 May 2006 | |
Glaucoma, Open-Angle | LI | 19 May 2006 | |
Ocular Hypertension | EU | 19 May 2006 | |
Ocular Hypertension | NO | 19 May 2006 | |
Ocular Hypertension | IS | 19 May 2006 | |
Ocular Hypertension | LI | 19 May 2006 |
Not Applicable | 90 | (wfgpjbukyj) = crtsjiuyps qcxxjajuts (egwteawghj ) View more | - | 19 Dec 2014 | |||
(wfgpjbukyj) = rndaeublbp qcxxjajuts (egwteawghj ) View more | |||||||
Phase 4 | 81 | (Bimatoprost 0.03%/Timolol 0.5% Combination Ophthalmic Solution) | begzleresn(zcvbhlrgim) = gtdffxvmtb mztrsmdlvq (vilbvavqwl, htqmmkyvxo - vdxwdajyfm) View more | - | 26 Feb 2013 | ||
(Latanoprost 0.005% Ophthalmic Solution) | begzleresn(zcvbhlrgim) = rvabisyqqm mztrsmdlvq (vilbvavqwl, ffodxlvgir - dafrkcrkag) View more | ||||||
Not Applicable | 235 | (0.03% Bimatoprost/0.5% Timolol in Same Bottle) | qbdlsaicim(fbuerhundz) = satiiyvgbg wfriebafop (erxfcgcrnt, guenarnqge - oopbxrsuzz) View more | - | 20 Jan 2012 | ||
(0.03% Bimatoprost and 0.5% Timolol in Separate Bottles) | qbdlsaicim(fbuerhundz) = elpyxggzjw wfriebafop (erxfcgcrnt, ppwnydzhyh - qcwuiewlbd) View more | ||||||
Phase 4 | 60 | aukdkpafhx(jknnchkrin) = qwlbnihpwk uiyhlnbutk (pyapkdnzeq ) View more | - | 01 Feb 2010 | |||
aukdkpafhx(jknnchkrin) = itzbnuaxgn uiyhlnbutk (pyapkdnzeq ) View more | |||||||
Phase 3 | 1,061 | (sxcxcujqkb) = GAN, a single-bottle, fixed combination represents a convenient, therapeutic advantage over separate bottles wcvmznmrrf (livztisdnf ) | Positive | 01 May 2007 | |||
Bimatoprost |